Cannabis and Psychosis Through the Lens of DSM-5
Nathan Pearson, James H. Berry
International Journal of Environmental Research and Public Health October 28, 2019 DOI: 10.3390/ijerph16214149 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Case report Peer reviewed |
|---|---|
| Topics | Cannabis |
| Keywords | Psychosis Schizophrenia object-oriented programming Context archaeology Dsm-5 Clinical psychology |
| Citations | 44 |
| Key findings | Cannabis intoxication, Cannabis-Induced Psychotic Disorder, and Schizophrenia can be understood along a continuum, with Cannabis-Induced Psychotic Disorder heavily associated with future schizophrenia diagnoses. |
Abstract
Evidence for an association between cannabis and psychosis has been documented in literature in many forms including experimental studies, epidemiological data, and case series. The association has implications for psychotic outcomes ranging from mild to severe and occurring over minutes to years. Due to the huge variety of exposures and outcome measures reported, creating a coherent account of all the available information is difficult. A useful way to conceptualize these wide-ranging results is to consider the association between cannabis and psychosis as it occurs within the context of widely used DSM-5 diagnoses. In the present review we examine cannabis/psychosis associations as they pertain to Cannabis Intoxication, Cannabis-Induced Psychotic Disorder, and Schizophrenia. This allows for an understanding of the cannabis and psychosis association along something approaching a continuum. Cannabis intoxication becomes Cannabis-Induced Psychotic Disorder once certain severity and duration criteria are met and Cannabis-Induced Psychotic Disorder is heavily associated with future schizophrenia diagnoses.
Comparable studies
Other narrative reviews on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Causal association between cannabis and psychosis: examination of the evidence | 2004 | Review | |
| Cannabis sativa: A comprehensive ethnopharmacological review of a medicinal plant with a long history. General (historical and pharmacological review) | 2018 | Review | |
| Psychiatric effects of cannabis | 2001 | Review | |
| Beyond THC: The New Generation of Cannabinoid Designer Drugs | 2011 | Review | |
| Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug | 2006 | Review |
Citations in the library
Cited by 8
- The Association Between Cannabis Use and Schizophrenia: Causative or Curative? A Systematic Review Cureus July 21, 2020
- Relação entre uso de cannabis e a esquizofrenia: uma revisão de literatura Brazilian Journal of Health Review September 21, 2023
- Cannabis Use and Psychosis – Modern Views on the Problem. Narrative Synthesis Medicina 2021
- Cannabis sativa – A matter of physical, mental, and social health Eastern Journal of Medical Sciences December 20, 2022
- Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen Frontiers in Psychiatry April 23, 2024
and 3 more in the library
Cites 24
- Gone to Pot – A Review of the Association between Cannabis and Psychosis Frontiers in Psychiatry May 22, 2014
- “Spiceophrenia”: a systematic overview of “Spice”‐related psychopathological issues and a case report Human Psychopharmacology: Clinical and Experimental July 1, 2013
- A Clinical and Metabolic Study of Acute Intoxication with Cannabis Sativa and its Role in the Model Psychoses Journal of Mental Science October 1, 1958
- Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses Psychopharmacology September 2, 2016
- Shall we really say goodbye to first rank symptoms? European Psychiatry July 17, 2016
and 19 more in the library